MORTALITY (%) | OR (95% CI) | P VALUES | ||
---|---|---|---|---|
SEX | Male | 64.7 | 1.44 (1.15, 1.80) | 0.0013 |
Female | 56 | |||
AGE (YEARS) | ≥ 50 | 66.5 | 4.42 (3.19, 6.10) | < .0001 |
18—49 | 31 | |||
COPD | Yes | 60.7 | 0.97 (0.77, 1.23) | 0.8 |
No | 61.4 | |||
HF | Yes | 64.3 | 1.19 (0.90, 1.56) | 0.22 |
No | 60.3 | |||
DM | Yes | 66.4 | 1.37 (1.06, 1.76) | 0.014 |
No | 59.1 | |||
HTN | Yes | 62.6 | 1.23 (0.96, 1.56) | 0.095 |
No | 57.7 | |||
CKD | Yes | 71.8 | 1.85 (1.41, 2.44) | < .0001 |
No | 57.9 | |||
TROPONIN (NG/L) | > 28 | 70.9 | 1.7 (1.26, 2.29) | 0.0004 |
≤ 28 | 58.9 | |||
CREATININE (MG/DL) | > 1.5 | 75.1 | 2.2 (1.61, 2.99) | < .0001 |
≤ 1.5 | 57.9 | |||
CRP (MG/L) | > 100 | 59 | 0.88 (0.69, 1.11) | 0.28 |
≤ 100 | 62.1 | |||
LYMPHOCYTES (ΜL) | ≤ 1 | 62.2 | 0.82 (0.63, 1.07) | 0.14 |
> 1 | 57.4 | |||
NT-PROBN (PG/ML) | > 88 | 63.6 | 1.16 (0.91, 1.48) | 0.23 |
≤ 88 | 60.1 | |||
HFNC DURATION | > 24 h | 67.2 | 2.16 (1.71, 2.74) | < .0001 |
≤ 24 h | 48.6 |